# STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)

Study · id `cardio:ct-nct07278310` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07278310](<https://clinicaltrials.gov/study/NCT07278310>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07278310

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1025 participants.

## Technical summary

Registry record NCT07278310. Randomized; single masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2028-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1025 participants (planned count; ClinicalTrials.gov record NCT07278310, source copy `cardio:ctgov-nct07278310-2026-04-09`, retrieved 2026-10-26)
- Planned start: 2026-04 (anticipated) (ClinicalTrials.gov record NCT07278310, source copy `cardio:ctgov-nct07278310-2026-04-09`, retrieved 2026-10-26)
- Primary completion: 2028-04 (anticipated) (ClinicalTrials.gov record NCT07278310, source copy `cardio:ctgov-nct07278310-2026-04-09`, retrieved 2026-10-26)
- Completion: 2028-04 (anticipated) (ClinicalTrials.gov record NCT07278310, source copy `cardio:ctgov-nct07278310-2026-04-09`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07278310, source copy `cardio:ctgov-nct07278310-2026-04-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07278310-2026-04-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
- Condition: Symptomatic Severe Native Aortic Stenosis
- Condition: Aortic Stenosis
- Intervention (Device): TAVR Device
- Intervention (Device): Siegel TAVR Device
- Lead sponsor: MiRus
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: 008a73fa459db3275bfab0bccc049178a5f44e9e213b164f68071bfb431a4da7
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
